Address
Email address
Phone number
https://cranfeld.comCranfeld - CranfeldCranfeld Clinicu eesmärk on teostada kvaliteetseid ja kiireid terviseuuringuid, et aidata avastada varakult võimalikke tervisemuresid.
Name
Svergest OÜ
Registry code
11928515
VAT number
EE102701977
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
21.04.2010 (15)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
68201 - Rental and operating of own or leased real estate
-
-3 378 €
-
-
858 107 €
0
Submitted
No tax arrears
-0%
-0%
| Owner | Representative | Beneficial owner | |
|---|---|---|---|
| Tarmo Laanetu
| - | Board member | Indirect ownership |
| OÜ CRANFELD INVEST 11015909 | 100% - 2 556.00 EUR | - | - |
| Owner | Representative | Beneficial owner | |
|---|---|---|---|
| Kesk Estates OÜ 12179719 | 50% - 1 250.00 EUR | - | - |
| 2019 29.09.2020 | 2020 04.06.2021 | 2021 23.02.2022 | 2022 17.05.2023 | 2023 28.06.2024 | 2024 14.07.2025 | |
|---|---|---|---|---|---|---|
| Total Revenue | - | - | - | - | - | - |
| Net profit (loss) for the period | -66 524 € | 329 327 € | 910 292 € | 39 663 € | 41 203 € | -3 378 € |
| Profit Margin | - | - | - | - | - | - |
| Current Assets | 25 088 € | 6 € | 593 744 € | 611 040 € | 628 389 € | 13 526 € |
| Fixed Assets | 398 926 € | 735 701 € | 836 268 € | 858 635 € | 882 489 € | 900 352 € |
| Total Assets | 424 014 € | 735 707 € | 1 430 012 € | 1 469 675 € | 1 510 878 € | 913 878 € |
| Current Liabilities | 233 627 € | 215 993 € | 6 € | 6 € | 6 € | 1 256 € |
| Non Current Liabilities | - | - | - | - | - | 54 515 € |
| Total Liabilities | - | - | - | - | - | 55 771 € |
| Share Capital | - | - | - | - | - | - |
| Equity | 190 387 € | 519 714 € | 1 430 006 € | 1 469 669 € | 1 510 872 € | 858 107 € |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2025 Q4 | 0 € | - | - | - |
| 2025 Q3 | 0 € | - | - | - |
| 2025 Q2 | 0 € | 1 978 € | 0 € | - |
| 2025 Q1 | 10 000 € | 226 € | 0 € | - |
| 2024 Q4 | 0 € | - | - | - |
| 2024 Q3 | 0 € | - | - | - |
| 2024 Q2 | 0 € | - | - | - |
| 2024 Q1 | 0 € | - | - | - |
